GLP1R and Parkinson disease: The GLP-1R agonist NLY01 inhibited inflammation by reducing microglial activation in the brain, reduced DAergic neuron loss in the SN, and prolonged the lifespans of PD model mice generated by α-Syn preformed fibril (α-Syn PFF) injection into the Str [59].